CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
63
PTPIF Quote, Financials, Valuation and Earnings
Last price:
$0.5300
Seasonality move
:
12.87%
Day range:
$0.5267 - $0.5267
52-week range:
$0.3900 - $0.5327
Dividend yield:
0.07%
P/E ratio:
--
P/S ratio:
22.49x
P/B ratio:
17.49x
Volume:
--
Avg. volume:
20.4K
1-year change:
17.04%
Market cap:
$45.6B
Revenue:
$1.8B
EPS (TTM):
-$0.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, PT Chandra Asri Pacific Tbk has -- downside to fair value with a price target of -- per share.
PTPIF vs. S&P 500
-
Over the past 5 trading days, PT Chandra Asri Pacific Tbk has overperformed the S&P 500 by 36.21% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
PT Chandra Asri Pacific Tbk does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PT Chandra Asri Pacific Tbk has grown year-over-year revenues for 2 quarters straight. In the most recent quarter PT Chandra Asri Pacific Tbk reported revenues of $622.1M.
Earnings Growth
-
PT Chandra Asri Pacific Tbk earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter PT Chandra Asri Pacific Tbk reported earnings per share of -$0.00.
Enterprise value:
46.5B
EV / Invested capital:
8.28x
Price / LTM sales:
22.49x
EV / EBIT:
832.47x
EV / Revenue:
24.01x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
752.07x
Gross Profit (TTM):
$53.6M
Return On Assets:
-1.12%
Net Income Margin (TTM):
-3.19%
Return On Equity:
-2.09%
Return On Invested Capital:
-1.23%
Operating Margin:
-3.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.2B | $2.1B | $1.9B | $471.9M | $622.1M | |
| Gross Profit | -$2.6M | $49M | $53.6M | $520K | $5.8M | |
| Operating Income | -$108.9M | -$61.8M | -$50.6M | -$29.3M | -$23.2M | |
| EBITDA | -$76.1M | $28.6M | $61.8M | -$9M | $2.5M | |
| Diluted EPS | -$0.00 | -$0.01 | -$0.00 | -$0.01 | -$0.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $2.9B | $2.1B | $2.5B | $2.9B | |
| Total Assets | $3.5B | $5B | $5B | $5.4B | $6.1B | |
| Current Liabilities | $679.5M | $499.2M | $367.8M | $601.9M | $411.7M | |
| Total Liabilities | $1.6B | $2.1B | $2.1B | $2.4B | $3B | |
| Total Equity | $1.9B | $2.9B | $2.9B | $3B | $3.1B | |
| Total Debt | $817M | $1.5B | $1.7B | $1.9B | $2.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -$538.8M | -$150.6M | $61.9M | -$139.5M | -$670K | |
| Cash From Financing | $129M | $250.3M | $734.1M | $117.3M | $688.4M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
PTPIF
Sector
Market Cap
$45.6B
$18.3M
Price % of 52-Week High
98.87%
63.37%
Dividend Yield
0.07%
0%
Shareholder Yield
--
1.21%
1-Year Price Total Return
17.04%
-16.26%
Beta (5-Year)
-10.382
0.782
Dividend yield:
0.07%
Annualized payout:
$0.00
Payout ratio:
-48.64%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$0.4416
200-day SMA
Buy
Level
$0.4829
Bollinger Bands (100)
Buy
Level
0.4097 - 0.5097
Chaikin Money Flow
Buy
Level
715.7K
20-day SMA
Buy
Level
$0.4109
Relative Strength Index (RSI14)
Buy
Level
92.1335
ADX Line
Buy
Level
70.2246
Williams %R
Sell
Level
-4.2194
50-day SMA
Buy
Level
$0.4211
MACD (12, 26)
Buy
Level
0.0186
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
987.8K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (10.4961)
Sell
CA Score
(Annual)
Level (-0.4133)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.7242)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PT Chandra Asri Petrochemical Tbk produces petrochemicals. Its products are olefins, polyolefins, styrene monomer, butadiene, and its byproducts. The company operates through Olefin; Polyolefin; Styrene monomer; Butadiene; Methyl Tertiary Butyl Ether (MTBE) and Butene-1 and Tanks and jetty rental. It generates maximum revenue from the polyolefins segment. The Polyolefins segment comprises the manufacturing of polyethylene and polypropylene petrochemicals.
Stock Forecast FAQ
In the current month, PTPIF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PTPIF average analyst price target in the past 3 months is --.
-
Where Will PT Chandra Asri Pacific Tbk Stock Be In 1 Year?
According to analysts, the consensus estimate is that PT Chandra Asri Pacific Tbk share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PT Chandra Asri Pacific Tbk?
Analysts are divided on their view about PT Chandra Asri Pacific Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Chandra Asri Pacific Tbk is a Sell and believe this share price will rise from its current level to --.
-
What Is PT Chandra Asri Pacific Tbk's Price Target?
The price target for PT Chandra Asri Pacific Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PTPIF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PT Chandra Asri Pacific Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PTPIF?
You can purchase shares of PT Chandra Asri Pacific Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Chandra Asri Pacific Tbk shares.
-
What Is The PT Chandra Asri Pacific Tbk Share Price Today?
PT Chandra Asri Pacific Tbk was last trading at $0.5300 per share. This represents the most recent stock quote for PT Chandra Asri Pacific Tbk. Yesterday, PT Chandra Asri Pacific Tbk closed at $0.5267 per share.
-
How To Buy PT Chandra Asri Pacific Tbk Stock Online?
In order to purchase PT Chandra Asri Pacific Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
52
SRPT alert for May 8
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 23.38% over the past day.
